Perrigo Europe Invest
0439.658.834 · rovalta.com · 27/09/2026
Perrigo Europe Invest
Financial year 2025 · Closed on 31/12/2025
Overview
Identity
Source · BCE/KBOPerrigo Europe Invest is a Public limited company incorporated in 1989. Its registered office is in Gent.
- Legal situation
- Normal situation
- BCE/KBO no. / VAT
- BE 0439.658.834
- Incorporation
- 20/12/1989
- Legal form
- Public limited company
- Registered office
- Gaston Crommenlaan 6 box 606
9050 Gent · FlandreSee on map - Contributed capital
- 1 623 649 604,00 €
- Latest accounts
- 31/12/2025
Joint committees (1)
- 100
Financials
Source · NBB, 25 filingsTrend over 19 financial years
| 2025 | 2023 | 2022 | 2021 | 2020 | |||||
|---|---|---|---|---|---|---|---|---|---|
| Income statement | |||||||||
| Gross margin | – | – | – | – | – | ||||
| EBITDA | -63,8 k € | -270% | -17,3 k € | +52.1% | -36 k € | -66.5% | -21,6 k € | +58.0% | -51,4 k € |
| Operating result | -63,8 k € | -270% | -17,3 k € | +52.1% | -36 k € | -66.5% | -21,6 k € | +58.0% | -51,4 k € |
| Net result | 40,9 M € | -5.7% | 43,4 M € | -14.1% | 50,5 M € | +13.0% | 44,7 M € | +14360% | -313,3 k € |
| Balance sheet | |||||||||
| Equity | 1,7 Md € | +0.1% | 1,7 Md € | +0.0% | 1,7 Md € | +20.1% | 1,4 Md € | -1.1% | 1,4 Md € |
| Total assets | 1,7 Md € | -0.1% | 1,7 Md € | +0.3% | 1,7 Md € | +19.9% | 1,4 Md € | +0.0% | 1,4 Md € |
| Cash | – | – | – | – | – | ||||
| Debts | 39,5 M € | -8.1% | 43 M € | +13.7% | 37,8 M € | +13.5% | 33,3 M € | +85.1% | 18 M € |
| Other | |||||||||
| Workforce | – | – | – | – | – | ||||
Valuation
Indicative valuation
As an indication, this company is worth
Board of directors
Source · NBB, accounts to 31/12/20254 active · 44 ended
Active mandates
Ended mandates
Other companies at this address
Gaston Crommenlaan 6 9050 Gent| Company | CBE no. |
|---|---|
BRAVX● Active | 0834.939.871 |
LIGHTHOUSE INTELLIGENCE● Active | 0676.420.293 |
Oce-Bio● Active | 0442.861.022 |
omega pharma group● Active | 0837.048.632 |
| 0884.084.724 | |
OMEGA PHARMA INTERNATIONAL● Active | 0807.596.363 |
OMEGA PHARMA TRADING● Active | 0417.092.080 |
Perrigo Belgium● Active | 0417.132.860 |
Perrigo Capital● Active | 0430.784.027 |
Perrigo Holding● Active | 0431.676.229 |
TM BRAVO4 CIVIEL● Active | 0787.232.501 |
TM BRAVO-4 KOEPEL-EPC● Active | 1008.974.796 |
TM Goedingebrug● Active | 1039.143.281 |
| 1035.016.328 |
Financials
Full financial information
Source · NBB| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|
| Type of account | Full model | Full model | Full model | Full model | Full model | Full model |
| Start of the financial year | 01/01/2025 | 01/01/2024 | 01/01/2023 | 01/01/2022 | 01/01/2021 | 01/01/2020 |
| Closing of the financial year | 31/12/2025 | 31/12/2024 | 31/12/2023 | 31/12/2022 | 31/12/2021 | 31/12/2020 |
| Length of the financial year | 12 months | 12 months | 12 months | 12 months | 12 months | 12 months |
| Filing date | 07/07/2026 | 18/06/2025 | 22/05/2024 | 25/05/2023 | 17/06/2022 | 14/06/2021 |
| General meeting | 29/06/2026 | 20/05/2025 | 19/04/2024 | 11/05/2023 | 12/05/2022 | 17/05/2021 |
| Currency of the financial year | EUR | EUR | EUR | EUR | EUR | EUR |
| NBB quality label | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls |
Financial ratios
Source · NBBLooking for more information about this company?
Try for freeAnnual accounts filings
Source · NBB, 25 filings| Model | Closing | General meeting | Filed | Language | Document |
|---|---|---|---|---|---|
| Full model | 31/12/2025 | 29/06/2026 | 07/07/2026 | Dutch | |
| Full model | 31/12/2024 | 20/05/2025 | 18/06/2025 | Dutch | |
| Full model | 31/12/2023 | 19/04/2024 | 22/05/2024 | Dutch | |
| Full model | 31/12/2022 | 11/05/2023 | 25/05/2023 | Dutch | |
| Full model | 31/12/2021 | 12/05/2022 | 17/06/2022 | Dutch | |
| Full model | 31/12/2020 | 17/05/2021 | 14/06/2021 | Dutch | |
| Full model | 31/12/2019 | 14/05/2020 | 11/06/2020 | Dutch | |
| Full model | 31/12/2018 | 09/05/2019 | 24/05/2019 | Dutch | |
| Full model | 31/12/2017 | 24/04/2018 | 24/05/2018 | Dutch | |
| Full model | 31/12/2016 | 16/05/2017 | 13/06/2017 | Dutch | |
| Consolidated accounts | 31/12/2016 | 16/05/2017 | 19/06/2017 | Dutch | |
| Full model | 31/12/2015 | 20/05/2016 | 17/06/2016 | Dutch | |
| Consolidated accounts | 31/12/2015 | 22/07/2016 | 27/07/2016 | Dutch | |
| Full model | 31/12/2014 | 28/04/2015 | 27/05/2015 | Dutch | |
| Consolidated accounts | 31/12/2014 | 28/04/2015 | 27/05/2015 | Dutch | |
| Full model | 31/12/2013 | 22/04/2014 | 12/05/2014 | Dutch | |
| Consolidated accounts | 31/12/2013 | 22/04/2014 | 12/05/2014 | Dutch | |
| Full model | 31/12/2012 | 26/06/2013 | 15/07/2013 | Dutch | |
| Consolidated accounts | 31/12/2012 | 26/06/2013 | 12/07/2013 | Dutch | |
| Abridged model | 31/12/2011 | 27/06/2012 | 10/07/2012 | Dutch | |
| Abridged model | 31/12/2010 | 29/06/2011 | 26/07/2011 | Dutch | |
| Abridged model | 31/12/2009 | 30/06/2010 | 30/08/2010 | Dutch | |
| Abridged model | 31/12/2008 | 24/06/2009 | 29/09/2009 | Dutch | |
| Abridged model | 31/12/2007 | 16/07/2008 | 20/08/2008 | Dutch |
Valuation
Indicative valuation
As an indication, this company is worth
more than 1.000 M€
The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.
Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.
Directors & structure
Board of directors
Source · NBB, accounts to 31/12/20254 active · 44 ended
Active mandates
Ended mandates
Ownership and network
Looking for more information about this company?
Try for freePublications
Belgian Official Gazette publications
Source · Belgian Official Gazette- Mandates08/06/2026ONTSLAGEN - BENOEMINGEN
- Mandates16/12/2025ONTSLAGEN - BENOEMINGEN
- Mandates18/06/2024ONTSLAGEN - BENOEMINGEN
- Registered office07/03/2024MAATSCHAPPELIJKE ZETEL
- Mandates09/03/2023ONTSLAGEN - BENOEMINGEN
- Mandates05/01/2023ONTSLAGEN - BENOEMINGEN
- Capital / shares15/07/2022STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, ) - DIVERSEN - KAPITAAL - AANDELEN
- Mandates16/06/2022ONTSLAGEN - BENOEMINGEN
Similar companies
Similar companies
A company's peers, by sector and size, are included in the Business plan.
See the Business planTimeline
Timeline
- 22/05/2026nominationJonas Dhaenens — bestuurder
- 2025Annual accounts 202540,9 M €↓
- 20/05/2025nominationBDO Bedrijfsrevisoren BV — commissaris
- 13/05/2024nominationSonia Hollies — bestuurder
- 19/04/2024nominationPaul Eelen — commissaris
- 2023Annual accounts 202343,4 M €↓
- 27/01/2023nominationMagali Verbraeken — bestuurder
- 2022Annual accounts 202250,5 M €↑
- 14/06/2022augmentation_capital
- 12/05/2022nominationChristophe Van Damme — bestuurder
- 12/05/2022reconductionSvend Andersen — bestuurder
- 2021Annual accounts 202144,7 M €↑
- 2020Annual accounts 2020-313,3 k €↑
- 2019Annual accounts 2019-4,4 M €↑
- 2018Annual accounts 2018-5,1 M €↑
- 2018Name changePERRIGO EUROPE INVEST
- 2017Annual accounts 2017-15,2 M €↑
- 2016Annual accounts 2016-15,6 M €↓
- 2015Annual accounts 201529,5 M €↓
- 2014Annual accounts 201438,6 M €↑
- 2013Annual accounts 201334,9 M €↓
- 2012Annual accounts 201237,9 M €↑
- 2012Name changeOMEGA PHARMA INVEST
- 2011Annual accounts 201113,3 M €↑
- 2010Annual accounts 20106,5 M €↓
- 2009Annual accounts 20097,8 M €↑
- 2008Annual accounts 20082 M €↓
- 2007Annual accounts 200732,9 M €↑
- 2006Annual accounts 200612 M €
- 2006Name changeCOUCKINVEST
- 20/12/1989IncorporationPublic limited company